GenePlaza
PrivateLast Round
Accelerator
Feb 1, 2018
Est. Valuation
$1.02M
Total Funding Raised
$60,000
Company Overview
GenePlaza operates in Healthcare & Life Sciences and is based in Brussels. Its latest recorded funding round was an Accelerator round in February 2018.
GenePlaza is a biotechnology company that operates a genetic app marketplace allowing users to upload raw DNA data to receive personalized genetic reports and insights.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Healthcare Analytics
Business Model
B2C
Customer Profile
Usage-Based SaaS, Hardware Sales
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GenePlaza Comparables
Compare GenePlaza with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MyGenomeBox | 87% | |
| Sequencing.com | 81% | |
| Genomelink | 79% |
For institutional investors. Book with your work email.
GenePlaza Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
GenePlaza Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Start it X | Accelerator |
| imec.istart | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 1, 2018
$60K round led by imec.istart
For institutional investors. Book with your work email.
GenePlaza Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about GenePlaza's valuation, stock price, and market status.
Is GenePlaza a public or private company?
GenePlaza is a private company.
What is the current stock price of GenePlaza?
GenePlaza is a private company, so its shares have no public market price. Caplight tracks GenePlaza's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is GenePlaza worth (valuation)?
GenePlaza's valuation is estimated at $1.0M based on funding round data.
Can I buy GenePlaza stock?
GenePlaza shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was GenePlaza's last funding round?
GenePlaza's most recent funding round was Accelerator on February 1, 2018.
Who are the main investors in GenePlaza?
Key investors in GenePlaza include imec.istart.
Will GenePlaza IPO soon?
No public IPO plans have been announced for GenePlaza.
How can I track GenePlaza secondary market activity?
Caplight tracks bids, offers, and trades in GenePlaza's shares on secondary markets.